3//SEC Filing
PureTech Health LLC 3
Accession 0000899243-22-002890
CIK 0001805087other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:30 PM ET
Size
11.2 KB
Accession
0000899243-22-002890
Insider Transaction Report
Form 3
GELESIS HOLDINGS, INC.NYSE: GLS
PureTech Health plc
10% Owner
Holdings
- 16,727,582(indirect: See footnote)
Common Stock
- (indirect: See footnote)
Stock Option (Right to Buy)
Exercise: $4.05Exp: 2028-07-17→ Common Stock (77,760 underlying) - (indirect: See footnote)
Stock Warrant
Exercise: $0.02Exp: 2023-08-16→ Common Stock (216,208 underlying) - (indirect: See footnote)
Earnout Shares
→ Common Stock (4,526,622 underlying) - (indirect: See footnote)
Stock Option (Right to Buy)
Exercise: $4.05Exp: 2027-06-15→ Common Stock (77,760 underlying)
PureTech Health LLC
10% Owner
Holdings
- (indirect: See footnote)
Earnout Shares
→ Common Stock (4,526,622 underlying) - 16,727,582(indirect: See footnote)
Common Stock
- (indirect: See footnote)
Stock Option (Right to Buy)
Exercise: $4.05Exp: 2027-06-15→ Common Stock (77,760 underlying) - (indirect: See footnote)
Stock Option (Right to Buy)
Exercise: $4.05Exp: 2028-07-17→ Common Stock (77,760 underlying) - (indirect: See footnote)
Stock Warrant
Exercise: $0.02Exp: 2023-08-16→ Common Stock (216,208 underlying)
Footnotes (5)
- [F1]PureTech Health LLC directly holds all of the securities reported in this Form 3. PureTech Health plc is the parent company of PureTech Health LLC, and has the power to direct the voting and disposition of securities held by PureTech Health LLC.
- [F2]The stock option is currently vested and exercisable.
- [F3]The stock option is currently vested and exercisable.
- [F4]The warrant is currently exercisable.
- [F5]On January 13, 2022, the reporting person received the right to acquire certain shares of the Issuer's Common Stock (the "Earnout Shares") pursuant to the Business Combination Agreement ("BCA") dated as of July 19, 2021, as amended on November 8, 2021, by and among Capstar Special Purpose Acquisition Corp., CPSR Merger Sub and Gelesis, Inc. ("Private Gelesis"). The Earnout Shares shall vest and be released upon the satisfaction of certain share price vesting conditions prior to January 13, 2027, as set forth in the BCA.
Documents
Issuer
GELESIS HOLDINGS, INC.
CIK 0001805087
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001727395
Filing Metadata
- Form type
- 3
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 4:30 PM ET
- Size
- 11.2 KB